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Abstract
The capacity of the liver to regenerate is an important clinical issue after major hepatectomies 
and makes the difference between life and death in some cases of post-operative malfunction 
when the liver remnant is too small or has an impaired regenerative capacity. Several approaches 
have been tested to stimulate hepatic regeneration after post-operative hepatic failure syndrome; 
however, they have produced controversial results. A quick, simple, and harmless method that 
can be used intraoperatively and capable of promoting an increased regenerative capacity of the 
remaining liver would be very welcome. Thus, based on the data in the literature, we presented 
low-power laser irradiation (LPLI) as a quick, simple, and harmless method to improve liver 
regeneration after major hepatectomies. This article highlights the current evidence about the 
effects of LPLI on liver regeneration, and also suggests laser therapy as an important tool for 
regenerative stimulation in clinical practice.
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Introduction
The regeneration capacity of the liver has been known 
since the Classical Era. It is reported by Hesiod in his 
Theogony, written in the eighth century BC, that the titan 
Prometheus, a defender of humanity who was known 
for his great intelligence, challenged Zeus by stealing fire 
from Olympus and providing it to mortals. Zeus punished 
Prometheus for this crime, leaving him chained to a rock 
on the top of the Caucasus Mountain for eternity while 
a big eagle would eat part of his liver every day, which 
would grow again the next day. Despite the immortality 
of Prometheus, the regenerative process of the liver, 
described in this passage from Greek mythology, is 
the most famous historical reference to the hepatic 
regeneration capacity in literature.
Biologically, the liver is an organ of complex metabolic 
functions. It receives blood efflux from the gut and 
the venous drainage of the pancreas and spleen. This 
anatomical particularity of continuous blood flow from 
the mesenteric region gives the liver some particular 
properties of supply. Indeed, it provides the specific 
biochemical characteristics to the hepatocyte, such as 
defense against toxic agents and a distinctive expression 
pattern of genes and proteins. Since the liver has 
paramount homeostatic functions in all species, the 
evolutionary process tried to preserve its maximum 
function. A remarkable characteristic of this organ is the 
ability to regenerate its functional mass without sacrificing 
the body homeostasis. This phenomenon is observed 
in all vertebrates, from fish to humans. In humans this 
remarkable regenerative capacity is very important in 
resectional surgery, since the liver is a common place 
of primary and secondary malignancies that must be 
resected.
Clinical Relevance of a Hepatectomy
Several benign and malignant diseases can affect the liver. 
For most of these tumors, resectional surgery is still the 
treatment of choice. Partial hepatectomy is the treatment 
chosen in many cases of hepatocellular carcinoma and 
liver metastases. Concerning hepatocellular carcinoma, 
many of these tumors appear as a result of cirrhosis and 
chronic hepatitis of various etiologies. In cases of primary 
liver cancer in patients with preserved liver function and 
the absence of a significant portal hypertension, liver 
resection may be the method of choice for the treatment, 
sometimes using the laparoscopic approach. In cases 
of metastatic disease, colorectal carcinoma is the most 
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prevalent, and liver resection remains the most effective 
treatment for this condition.
Recently, liver resection surgery has experienced an 
impressive evolution. Using the recognized regenerative 
capacity of the remnant liver, several strategies have 
been described for the surgical treatment of primary 
and secondary organ malignancies.1-3 Also, more 
sophisticated and minimally invasive techniques, such 
as laparoscopy and robotic surgery, that were once 
considered impossible, have been successfully used in 
performing hepatectomies. In cases of hepatocarcinoma 
(HCC), resection of more than one liver sector is common 
nowadays.2,4 Compensated cirrhotic patients with HCC 
now undergo liver resection, even using laparoscopic 
techniques. In all cases, the liver remnant is expected to 
regenerate. Unfortunately, this does not always happen.
Elderly and steatotic livers patients may have an impaired 
capacity of recovery after a major hepatecomies. 
Concerning colorectal liver metastasis, the utilization 
of pre-operative chemotherapies based on oxaliplatin 
or irinotecan also may lead to some conditions that 
impair the capacity of liver regeneration (steatohepatitis 
and sinusoidal obstruction).5 Unfortunately, in some 
cases the regenerative capacity of the remnant liver is 
compromised, either by the use of chemotherapy or the 
presence of chronic inflammation and fibrosis. Post-
operative hepatic failure is still a difficult condition to 
treat, since the remaining liver sometimes shows an 
unsatisfactory regeneration capacity. This means that 
the liver regeneration capacity is crucial after major 
hepatectomies and makes the difference between life 
and death in some cases when the liver remnant is very 
small or has an impaired regenerative capacity. Extended 
hepatectomy surgery carried out in 2 stages and preceded 
by maneuvers that stimulate liver regeneration is a recently 
developed strategy that has changed the resectability rate 
of hepatic tumors.
The Current Clinical Practice to Prevent Post-operative 
Hepatic Failure Syndrome After a Hepatectomy
In order to avoid the syndrome of liver failure in the 
post-operative period of a hepatectomy, various strategies 
have been used before carrying out a major hepatectomy. 
The first and most obvious and simple of these 
strategies is the correct selection of patients that should 
undergo surgery. Many patients with hepatocellular 
carcinoma as a result of chronic hepatitis or cirrhosis 
are not suitable for resection and are best treated by 
liver transplantation or ablative therapies such as arterial 
chemoembolization or percutaneous ablation (ethanol, 
microwaves, radiofrequency, electroporation). In the 
case of metastases, resection is the treatment with the 
highest cure rates, but many patients receive high doses of 
chemotherapy and show changes in the liver that affect its 
regenerative capacity in the post-operative period.
Several strategies have been tested in order to stimulate 
liver regeneration after hepatectomies. Since liver 
regeneration depends on the blood portal flow (rich in 
insulin, peptides, and hepatotrophic factors) that runs 
through the liver, pre-operatory portal vein embolization 
(PVE) deviates the portal flow to the contralateral lobe. 
The hemodynamic changes achieved by PVE lead to a 
blood portal overflow to the contralateral side, while 
maintaining the arterial blood supply in the affected 
lobe.6 This maneuver prevents necrosis of the effected 
lobe but induces hypertrophy of the contralateral lobe, 
increasing the function of the future remaining liver. 
There is evidence that the production of inflammatory 
cytokines, vessel regulators, and growth factors is involved 
in the hypertrophy process.3,6 What is theoretically 
achieved with PVE is an anticipation of the regenerative 
capacity of the remaining liver, which becomes stimulated 
pre-operatively. However, there are doubts about the 
possibility that PVE can offer an “extra” regenerative 
capacity in the remaining liver.
In some cases, PVE fails to induce hypertrophy of the 
contralateral lobe. This may be related to an unidentified 
regenerative dysfunction in the liver. In these cases, many 
health facilities understand that the patient should not 
undergo a hepatectomy, since liver failure in the post-
operative period is very likely to occur. Working as a 
selection criterion, this strategy can prevent death in the 
post-operative period of a major hepatectomy. On the 
other hand, other authors argue that it is necessary to try 
other alternatives in such cases.3 The technique known 
as ALPPS (Associated Liver Partition and Portal vein 
ligation for Staged hepatectomy) has been described as 
an efficient alternative to induce growth of the remaining 
liver when PVE fails.3,7,8 ALPPS is a 2-stage surgical 
strategy in which, in the first procedure, the liver is 
subjected to a partition and portal ligation on the affected 
lobe. This maneuver is believed to completely disconnect 
both sides of the liver, and a more efficient portal flow 
deviation can improve regeneration of the remnant. 
After 7–14 days, it is expected a large hypertrophy in 
the contralateral lobe, then the patient is submitted to 
a second surgery to remove the affected lobe. However, 
this method requires 2 major surgeries, and consequently 
promotes an increased length of hospital stay and the risk 
of biliary fistulas and infections.7,8
Is portal flow the only way to stimulate liver regeneration? 
Regeneration of solid organs is a complex process that 
comes in waves. Firstly, ancient proto-oncogenes are 
stimulated by aggression stimuli like ischemia or trauma. 
Then, several molecular pathways are mobilized in order 
to induce inflammation. Many of these pathways are 
promiscuous and may induce regenerative pathways. 
Afterwards, RNA messages are sent to cellular structures 
to promote hypertrophy and/or hyperplasia. The cells 
then need to duplicate, which consumes much energy.9,10 
Mitochondria are very important in this process, since 
they provide the necessary energy.11 Mitochondria have 
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photon receptors and may respond to light stimulation. 
Light can also stimulate melatonin production in the 
central nervous system (CNS), and melatonin has a 
recognized capacity to stimulate regeneration in some 
tissues and organs.11,12 So the question is, does light have 
the potential to induce liver regeneration? 
New Road – the Low-Power Laser Irradiation 
Light is known to be an important factor for the 
homeostasis of many tissues and organs. Absorption and 
utilization of vitamins, hormonal circadian cycles, and 
control of wakefulness and sleep systems are examples 
of light-dependent homeostatic systems. The LASER 
(light amplification by stimulated emission of radiation) 
invention, allowed to obtain light with high power and in 
certain wavelengths, facilitating its application in biology 
and allowing a new field of research related to the biological 
effects of radiation on animals and humans.12 As a result, 
by the 1970s there appeared the first satisfactory results of 
the biological effects of lasers, as it was found that LPLI 
caused the stimulation of healing in surgical wounds.13 
Following this line, further studies were conducted in this 
new field of research.
Currently, LPLI is used in clinical practice due to a very 
important physiological effect: the induction of cell 
proliferation.12,14 The stimulatory effect of LPLI on cell 
regeneration and consequent resolution of ischemic or 
mechanical problems in organs such as the skeletal muscle, 
heart, brain, and liver are well known.14 Furthermore, there 
is evidence that the gene or protein expressions of several 
growth factors, such as transforming growth factor-β 
(TGF-β), vascular endothelial growth factor (VEGF), 
platelet-derived growth factor (PDGF), and insulin-
like growth factor I (IGF-I), are elevated by LPLI.12,14 
Thus, it is clear that through the increased expressions 
of these growth factors, LPLI is able to enhance cellular 
proliferation and differentiation.
Until recently, there were few lines of research related to 
the action of LPLI on liver regeneration (see Table 1 and 
Figure 1). First, it was recognized that there is a universal 
photo-biological mechanism of the light in the terminal 
enzymes of the respiratory chain in mitochondria from 
eukaryotic cells.11 In this regard, some groups have 
studied the effects of lasers on mitochondrial function. 
It is reported in the literature that lasers have the ability 
to induce conformational changes in the structure of 
cytochromes from hepatocytes, thereby increasing the 
production of adenosine triphosphate (ATP).15-17 In this 
line, an increase in energy metabolism in the liver of a 
hepatectomizated rat exposed to laser treatment was 
observed.15-17 In a recent study, Barbosa and colleagues 
observed that 24 hours after laser exposure have already 
observed an important increase in ATP production.18 
In sum, these studies demonstrated that both high- and 
low-power lasers have the ability to increase the mitotic 
index and mitochondrial function in the remaining liver 
after different levels of partial resection (70% and 90%) 
in rats.15-19
In addition, Oron et al,20 in analyzing other parameters, 
demonstrated the effects of LPLI on liver regeneration 
in rats subjected to a 70% hepatectomy. Two days after 
the surgery and laser exposure, it was observed that the 
remaining liver had increased the newly formed blood 
vessels determined by 5-Bromo-2´deoxyuridine (BrdU 
immunostaining), as well as, had augmented the number 
of bone-marrow-derived mesenchymal stem cells (MSCs) 
determined by c-kit immunostaining. Thus, it was 
concluded that LPLI causes a significant improvement in 
hepatic regeneration through an increase in the formation 
of new hepatocytes, MSCs, and angiogenesis in the 
remaining liver.20
More recently, our group conducted further studies 
related to the effect of laser treatment in animals subjected 
to a partial hepatectomy. Using immunoblotting and 
immunostaining approaches, we investigated the main 
molecular mechanisms involved in liver regeneration 
of partially hepatectomized (70%) rats exposed to LPLI. 
Several studies have demonstrated that a hepatotrophic 
factor called hepatocyte growth factor (HGF), which binds 
to a specific receptor (c-Met) and comes from the family 
of tyrosine kinases, has an important role in the liver 
regeneration mechanism.9,10 The progression of the cell 
cycle can be regulated through activation or expression of 
specific proteins. Consequently, well-known intracellular 
signaling pathways such as Ras/Raf/MEK/Erk, PI3K/Akt/
eIF4E, PI3K/Akt/eNOS, and PLC-gamma/PKC may be 
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Figure 1. Details of the Laser Application Procedure. These images 
was based from previous studies.21,23
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involved in the regenerative effect of the laser in various 
tissues.12,14 This data led us to hypothesize the effect of the 
laser on the regenerative molecular pathway HGF → Met→ 
Akt and Erk 1/2. Then, 2 days after partial hepatectomy 
surgery and exposure to the laser in rats, we studied 
the remaining livers. Our results showed that LPLI can 
improve liver regeneration, as evidenced by increasing 
HGF protein expression and the phosphorylation levels 
of Met, Akt, and Erk 1/2, along with higher levels of 
PCNA and Ki-67 (established proliferating markers) in 
the remnant liver of partially hepatectomized rats.21
Once we demonstrated that LPLI was able to improve 
liver regeneration in partially hepatectomized rats, we 
also tried to demonstrate the same effects in elderly 
rats subjected to the same surgery. This is an important 
target for this adjuvant therapy, since studies in humans 
have demonstrated that those over 65 years having three 
to 5-fold higher fatal outcomes of liver disease when 
compared with those under 45 years old.22 Despite the 
remarkable results observed in young hepatectomized 
animals, LPLI failed to improve liver regeneration in 
elderly rats, as evidenced by the lack of increase in the 
phosphorylation levels of Met, Akt, and ERK1/2 in the 
liver. Also, we did not observe any significant improvement 
in HGF and PCNA protein expression.23 Taken together, 
the results of this study indicate that LPLI cannot induce 
any improvement in the hepatic regeneration process for 
at least 48 hours after 70% resection, which excludes LPLI 
as an auxiliary therapy in elderly hepatectomized rats.23
Conclusion
In the clinical context of a major hepatectomy, there is an 
ongoing need to prevent the syndrome of post-operative 
liver failure by dysfunction of the remaining liver. 
Techniques such as pre- and post-conditioning (ischemic, 
pharmacological, or related to hepatic hemodynamics) 
have been used with little convincing results to date. The 
vast majority of techniques that aim to advance or improve 
the regenerative capacity of the liver remnant require 
prior planning (e.g. PVE). When these pre-operative 
maneuvers are not performed because they are seen as 
superfluous or unnecessary is common the surgeon to 
come across in a very difficult intraoperative decisions 
in which the continuation with surgery means leaving 
a dangerously small liver remnant. When the decision 
is to proceed with the surgery, it is observed that liver 
failure may occur in the first post-operative days, which 
consequently causes encephalopathy and coagulopathy, 
ending in a fatal outcome in the majority of cases. Only 
intensive care support can be offered to patients who are 
in this situation because there is no way to improve the 
regenerative capacity of the remaining liver at that point.
There are doubts about whether low-power laser 
stimulation in tissues where there are nested neoplastic 
cells could stimulate their replication, leading to disease 
progression. In clinical practice, it is known that the use of 
Figure 2. LPLI-Induced Mechanisms Involved in the Enhancement 
of Hepatic Regeneration. The figure shows the effects of LPLI on 
hepatic regeneration. LPLI causes an increase in the mitotic index 
and mitochondrial function and augments the formation of new 
hepatocytes, MSCs, and angiogenesis in the remaining liver. Indeed, 
LPLI can improve liver regeneration, as evidenced by the enhanced 
regenerative molecular pathway HGF → Met→ Akt and Erk 1/2, 
along with higher levels of PCNA and Ki-67. LPLI: Low-Power Laser 
Irradiation, MSCs: bone-marrow-derived mesenchymal stem cells, 
HGF: hepatocyte growth factor, PCNA: proliferating cell nuclear 
antigen.
intraoperative ultrasound directly on the remaining liver 
is the most sensitive method for the detection of small 
tumors from 2–3 mm in diameter. Fortunately most of 
reference services in liver surgery have such equipment 
as routine. Therefore, an idea would be to conduct 
intraoperative ultrasonography in patients’ candidate 
to receive stimulation of LPLI. A quick, simple, and 
harmless method that can be used intraoperatively and 
capable of promoting an increased regenerative capacity 
of the remaining liver would be very welcome. 
Liver regeneration is a phenomenon related to a variety 
of different mechanisms. Portal flow deviation is the 
most utilized strategy to increase regeneration of the 
liver remnant prior to (e.g. PVE) or during (e.g. ALPSS) 
surgery, but other strategies might also be useful in 
the clinical setting. LPLI may be a useful and harmless 
intraoperative tool to improve the regenerative capacity 
of a small liver remnant. In sum, laser therapy to induce 
the improvement of hepatic regeneration is composed of 
a variety of mechanisms. In this sense, according to data 
from the literature and our experimental data, we can 
provide an overview of LPLI effects on liver regeneration 
(Figure 2). LPLI induces an increase in the mitotic index 
and mitochondrial function and augments the formation 
of new hepatocytes and MSCs along with angiogenesis 
in the remaining liver. Indeed, LPLI can improve liver 
regeneration, as documented by increasing HGF protein 
expression and the phosphorylation levels of Met, Akt, 
and Erk 1/2, along with higher levels of PCNA and Ki-
67. Therefore, in the near future, laser therapy could be 
an important tool for regenerative stimulation of the 
remaining liver during a large liver resection.
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